Navigation Links
Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
Date:11/15/2010

ore information can be found at www.regadobio.comContact:Ellen McDonald, Chief Business Officer, Regado Biosciences, 1-908-580-2113, emcdonald@regadobio.comMedia Contact:Tiberend Strategic Advisors, Inc.1-212-827-0020Andrew Mielach, amielach@tiberendstrategicadvisors.com
'/>"/>
SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
2. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
3. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
4. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
5. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
6. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
7. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
8. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
9. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
10. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
11. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ANGELES , Sept. 30, 2014   Easy ... shopping destination , today announced that it now offers ... . AirSense CPAPs are the first sleep apnea therapy ... it simple and easy to track and share real-time ... overall effectiveness of their CPAP therapy.  In addition, the ...
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... , Sept. 30, 2014 The Chinese wound ... population and rise in the incidence of lifestyle diseases, ... and in affordability of better quality of wound care ... market. Universal coverage of public health insurance schemes and ... stimulate demand. Based on the findings of primary and ...
Breaking Medicine Technology:Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2China Wound Care Market 2China Wound Care Market 3
(Date:9/30/2014)... Healthpointe is proud to announce that ... and ankle reconstruction surgeries to assist patients with severe ... specializes in the diagnosis and treatment of sports medicine, ... also trained to perform advanced Foot and Ankle Reconstruction ... is also fluent in Spanish. , Reconstructive surgical procedures ...
(Date:9/30/2014)... TX (PRWEB) September 30, 2014 ... Industry, 2009-2019 is a professional and in-depth market ... report firstly reviews the basic information of Cialis ... report then explores global and China’s top manufacturers ... value, and market share etc. , The report ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 To mark ... Editorial Board of Living with a Disability magazine ... light on hematological disorders as disabling conditions. ... more than a diagnosis to establish a disability related ... thrombocytomenia, myelofibrosis, hereditary telangiectasia, coagulation defects, polycythemia vera, and ...
(Date:9/30/2014)... Catalent Pharma Solutions (Stand 2C9), ... and development solutions for drugs, biologics and consumer ... the 25th Annual CPhI Worldwide Exhibition to be ... 9th. , Catalent is showcasing a number of ... show, including its facilities in China and Japan, ...
(Date:9/30/2014)... Jiwa Law Corporation, a personal injury law firm in Vancouver, ... free consultation for personal injury claims of their clients. This ... first time to meet the Vancouver ICBC lawyers will not ... what their rights are. The experts at Jiwa Law Corporation ... them what the law firm can do regarding their claim. ...
Breaking Medicine News(10 mins):Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 2Health News:Fellowship-Trained and Board-Certified Orthopedic Specialist Now Performing Advanced Foot & Ankle Reconstruction Surgeries 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Cialis Industry (CAS 171596-29-5) Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 2Health News:Catalent Showcases Advanced Technologies and Supply Capabilities at CPhI Worldwide Conference and Exhibition 3Health News:Jiwa Law Corporation Now Offers Personal Injury Consultation Without Any Charge 2
... Journal of the American Heart Association, had said that ... risk of heart attacks and developing heart disease than ... blood pressure remaining between 120 and 139, and the ... Blood pressure hovering in any one of these two ...
... the link between alcohol and certain type of cancers, ... DNA repair pathways. ,The study examined the reaction ... induce cancer formation, found in alcohol) with polyamines - ... usually considered to be beneficial to the body because ...
... Latest research shows that drinking coffee could decrease the ... two cohort studies that showed self-reported frequency of coffee ... adjustment for potential confounders, researchers say they found that ... almost 30 per cent, while those drinking one or ...
... A new innovative vaccine for flu is under pre-clinical phase ... protection against flu. //, ,Flu is caused by virus ... virus. . Flu is an extremely contagious condition and makes ... serious consequences: According to the World Health Organization, on average ...
... are working on using virtual reality to help patients ... ,In this research, scientists are creating simulating virtual realities ... through the similar experiences they had felt when they ... had left them unable to cope reality. Called exposure ...
... Wales may be one of the first scientists to develop ... is no single test that could exactly identify the disease.//, ... latest issue of the journal Psychiatry Research said that this ... effective as their tool can safely distinguish between the two ...
Cached Medicine News:Health News:Risk Of Heart Attack Increase From Pre-Hypertension 2Health News:New Flu Vaccine Can Give Lifetime Protection 2Health News:Schizophrenia Gets A New Diagnostic Tool 2
Polyester ribbon impregnated with conjugated Protein G - .13 OD per sq. cm....
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... glass (1.5x) Gonio lens will enable visualization ... 4 mirror lens is the industry preferred ... and features : , Crispest, clearest ... previously unattainable with Gonio lenses., 4 equally ...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: